Natixis Idera Pharmaceuticals, Inc. Transaction History

Natixis

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	BUY	$2.37 - $3.97 $672,610 - $1.13 Million	283,802 Added 61.72%	743,618 $1.99 Million
Q1 2019 May 15, 2019	BUY	$2.33 - $3.79 $69,900 - $113,700	30,000 Added 6.98%	459,816 $1.17 Million
Q3 2018 Nov 14, 2018	BUY	$5.53 - $11.36 $2.38 Million - $4.88 Million	429,816 New	429,816 $3.83 Million

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.